Discovery of 3-Chloro-<i>N</i>-{(<i>S</i>)-[3-(1-ethyl-1<i>H</i>-pyrazol-4-yl)phenyl][(2<i>S</i>)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor
作者:Shuji Yamamoto、Tsuyoshi Shibata、Kumi Abe、Koji Oda、Takeshi Aoki、Yasunori Kawakita、Hiroshi Kawamoto
DOI:10.1248/cpb.c16-00314
日期:——
inhibitory activity. Starting from 2-chloro-N-(S)-phenyl[(2S)-piperidin-2-yl]methyl}-3-(trifluoromethyl)benzamide (2, SSR504734), the introduction of heteroaromatic rings enabled an increase in the GlyT1 inhibitory activity. Subsequent optimization led to the identification of 3-chloro-N-(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidine-2-yl]methyl}- 4-(trifluoromethyl)pyridine-2-carboxamide (7w)
通过叠加不同的化学型来设计新型甘氨酸转运蛋白1(GlyT1)抑制剂,以增强其抑制活性。从2-氯-N-(S)-苯基[(2S)-哌啶-2-基]甲基} -3-(三氟甲基)苯甲酰胺(2,SSR504734)开始,杂芳环的引入使得能够增加GlyT1抑制活性。随后的优化导致鉴定3-氯-N-(S)-[3-(1-乙基-1H-吡唑-4-基)苯基] [(2S)-哌啶-2-基]甲基}- 4-(三氟甲基)吡啶-2-甲酰胺(7w),在大鼠中显示出强大的GlyT1抑制活性(IC50 = 1.8 nM),良好的血浆暴露和血浆对脑的渗透,足以评估该化合物的药理特性。